Answers are grounded in this paper and cite their sources.
. Our study reveals that UCH-L1 is an important regulator of double-negative prostate cancer tumor growth and progression, providing a promising therapeutic target for this subtype of metastatic prostate cancer.
No takes yet. Share an insight, caveat, or question.
Shiqin Liu (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: